Rachel Upthegrove

Has grant

Professor of Psychiatry

University of Birmingham

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Rachel Upthegrove is a Professor of Psychiatry at the University of Birmingham, UK. Her research encompasses various areas, including psychosis risk biomarkers, cognitive and mental health disorders, and the impact of diabetes following COVID-19 hospitalization. She has contributed to numerous articles focusing on the integration of structural brain alterations with symptoms of schizophrenia and the evaluation of social care practitioners’ experiences in applied healthcare research.

Recent Grants

Grant: Open

Mental Health Mission: Midlands Translational Centre of Excellence

Open Date: 2023-03-01

Close Date: 2028-03-01

Grant: Open

NIHR Biomedical Research Centre Oxford Health: Molecular Targets Theme

Open Date: 2022-12-01

Close Date: 2027-11-01

Grant: Close

Early Psychosis Informatics into Care: EPICare

Open Date: 2021-11-01

Close Date: 2022-10-01

Grant: Close

PRESCIENT

Open Date: 2020-10-01

Close Date: 2025-06-01

Grant: Close

Inflammation and Oxidative stress in Early Psychosis: a multimodal data science and brain imaging approach

Open Date: 2020-09-27

Close Date: 2024-03-31

Articles (21)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Collaborators (95)

Nazrul Islam

Associate Professor of Epidemiology and Medical Statistics

University of Southampton

UNITED KINGDOM

Rachel Upthegrove

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (21)

Body fluid biomarkers and psychosis risk in The Accelerating Medicines Partnership® Schizophrenia Program: design considerations

An analysis on the role of glucagon-like peptide-1 receptor agonists in cognitive and mental health disorders

Depressive and Negative Symptoms in the Early and Established Stages of Schizophrenia: Integrating Structural Brain Alterations, Cognitive Performance, and Plasma Interleukin 6 Levels

Incidence of diabetes mellitus following hospitalisation for COVID-19 in the United Kingdom: A prospective observational study

Protecting and promoting editorial independence

Accelarated immune ageing is associated with COVID-19 disease severity.

The psychoneuroimmunology of Psychosis: Peeking past the clouds of Heterogeneity: Editorial

A Realist Evaluation of Social Care Practitioners' Experiences With and Understanding of Applied Healthcare Research

A systematic review of optical coherence tomography findings in adults with mild traumatic brain injury

A multivariate cognitive approach to predict social functioning in recent onset psychosis in response to computerized cognitive training

A realist review of medication optimisation of community dwelling service users with serious mental illness

A leaky umbrella has little value: evidence clearly indicates the serotonin system is implicated in depression

Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK

Impact of anxiety and depression across childhood and adolescence on adverse outcomes in young adulthood: a UK birth cohort study

Disentangling heterogeneity of psychosis expression in the general population: sex-specific moderation effects of environmental risk factors on symptom networks

Cognitive Remediation Works But How Should We Provide It? An Adaptive Randomized Controlled Trial of Delivery Methods Using a Patient Nominated Recovery Outcome in First-Episode Participants

Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls

Five-year illness trajectories across racial groups in the UK following a first episode psychosis

Novel and emerging treatments for major depression

Personality traits as risk factors for relapse or recurrence in major depression: a systematic review

Cognitive function in early-phase schizophrenia-spectrum disorder: IQ subtypes, brain volume and immune markers

Collaborators (95)

Nazrul Islam

Bronwen Connolly

Michael Llewellyn Rutter

Jonathan Heeney

Davies Adeloye

Daniel Peckham

Philip Corlett

Anne M. Doherty

Sherifat Oduola

Gerome Breen

Toby Pillinger

Trudie Chalder

Isabel Morales-Muñoz

Nazir I Lone

John R. Petrie

Carl Krynicki

Patricia Casey

Dr Sian Lowri Griffiths

Nigel D. Hart

Claire Sharpe

Pilar Rivera-Ortega

Luke Daines

David R Baldwin

Anthony Rostron

Ian Maidment

Peter Hellyer

Julie Whitney

John Busby

Jon Hazeldine

Danilo Arnone

Joanne Hodgekins

Timothy Nicholson

Gerry McCann

Matteo Cella

Paris Alexandros Lalousis

Charlotte Bolton

Simon Charles Wessely

Timothy Wallis

Michael Gibbons

Jim Wild

Salman Siddiqui

Sameer Jauhar

Karen Piper Hanley

David Erritzoe

Lucy Elizabeth Mary Finnigan

Tao Dong

Joseph Kambeitz

Lauren Robinson

John Deakin

Catherine Atkin

Neil Greening